Blood Advances | 2024
Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study.
Jain T, Estrada-Merly N, Queralt Salas M, Kim S, DeVos J, Chen M, Fang X, Kumar R, Andrade Campos M, Elmariah H, Agrawal V, Aljurf M, Ulrike Bacher V, Badar T, Badawy S, Ballen K, Beitinjaneh A, Bhatt V, Bredeson C, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi A, Ganguly S, Gergis U, Grunwald M, Hamad N, Hamilton B, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem M, Lad D, Liesveld J, Al Malki M, Malone AK, Murthy H, Ortí G, Patel S, Pawarode A, Perales M, van der Poel M, Ringden O, Rizzieri D, Rovo A, Savani B, Savoie M, Seo S, Solh M, Ustun C, Verdonck L, Wingard J, Wirk B, Bejanyan N, Jones R, Nishihori T, Oran B, Nakamura R, Scott B, Saber W, Gupta V
PubMed
PMID: 38916866
Abstract
Related Articles
CIBMTR Study #: CK21-01